title: Activation of CYP1A1 gene expression during primary culture of mouse hepatocytes.
abstract: Expression of CYP1A1 mRNA in mouse hepatocytes in primary culture was investigated. The expression was obvious on day 3 of culture without addition of any known ligands of the aryl hydrocarbon receptor and increased with culture period. Removal of insulin from and addition of hydrogen peroxide to the medium enhanced and suppressed the expression, respectively. The CYP1A1 mRNA expression was also enhanced in the presence of anti-oxidant, t-butylhydroquinone, in the medium. Several kinds of kinase inhibitors markedly increased the CYP1A1 mRNA expression. In contrast, the inhibitory expression was prolonged in the presence of okadaic acid, a potent inhibitor of serine/threonine phosphatase PP1 and PP2. These observations suggest that there might be a repressive pathway in the regulation of CYP1A1 mRNA expression and that the presently observed expression pathway differs at several points from those previously reported, such as ligand-activated aryl hydrocarbon receptor- or omeprazole-mediated expression. Modulation of CYP1A2 mRNA expression after exposing hepatocytes to agents affecting phosphorylation pathways differed from that of CYP1A1 mRNA. This implies that regulatory pathways for CYP1A1 and CYP1A2 expression may differ.
authors.affiliation: Department of Toxicology, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, Sugitani 2630, Toyama 930-0194, Japan.
authors.forename: Hisako
authors.initials: H
authors.lastname: Tamaki
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Sakuma
authors.forename: Yo-Ichi
authors.initials: Y
authors.lastname: Uchida
authors.forename: Atika
authors.initials: A
authors.lastname: Jaruchotikamol
authors.forename: Nobuo
authors.initials: N
authors.lastname: Nemoto
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D019363:Cytochrome P-450 CYP1A1 / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism; D019388:Cytochrome P-450 CYP1A2 / Q000235:genetics; D024202:Electrophoretic Mobility Shift Assay / Q000379:methods; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D019833:Genistein / Q000494:pharmacology; D022781:Hepatocytes / Q000201:enzymology*; D006861:Hydrogen Peroxide / Q000494:pharmacology; D006873:Hydroquinones / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D007529:Isoflavones / Q000494:pharmacology; D007701:Kinetin / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D019319:Okadaic Acid / Q000494:pharmacology; D010766:Phosphorylation / Q000187:drug effects; D011687:Purines / Q000494:pharmacology; D012333:RNA, Messenger / Q000187:drug effects; D000077546:Roscovitine; D013997:Time Factors; D015533:Transcriptional Activation
chemical_list: D004791:Enzyme Inhibitors; D006873:Hydroquinones; D007328:Insulin; D007529:Isoflavones; D011687:Purines; D012333:RNA, Messenger; D000077546:Roscovitine; D019319:Okadaic Acid; C004742:daidzein; C090046:olomoucine; D006861:Hydrogen Peroxide; C018855:2-tert-butylhydroquinone; D019833:Genistein; D019363:Cytochrome P-450 CYP1A1; D019388:Cytochrome P-450 CYP1A2; D007701:Kinetin